Viomycin
| File:Viomycin.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| Chemical and physical data | |
| Formula | C25H43N13O10 |
| Molar mass | 685.691 g/mol |
|
WikiDoc Resources for Viomycin |
|
Articles |
|---|
|
Most recent articles on Viomycin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Viomycin at Clinical Trials.gov Clinical Trials on Viomycin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Viomycin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Viomycin Risk calculators and risk factors for Viomycin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Viomycin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Viomycin sulfate (Viocin®) is an polypeptide antibiotic used in the treatment of tuberculosis. It is produced by the actinomycete Streptomyces puniceus, that binds to RNA and inhibits prokaryotic protein synthesis and certain forms of RNA splicing.
Administration
Intramuscular injection.
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Polypeptide antibiotics